The medical device MOWOOT has been developed and tested by the healthtech startup usMIMA biotech in collaboration with doctors and physiotherapists of the neuro-rehabilitation center Institut Guttmann.
Through hundreds of interviews with patients at Institut Guttman, the usMIMA team verified the enormous impact that chronic constipation has on the quality of life of people with spinal cord injuries. usMIMA investigated for months to develop a solution that would avoid the use of laxatives or reduce it to a minimum until they found the key: a medical device that reproduces very precisely the abdominal massages that the therapists of the Institut Guttmann administer to their patients to relieve the chronic constipation.
Dr. Eloy Opisso, executive coordinator of Institut Guttmann’s Office of Research and Innovation, explains how MOWOOT was developed.
The founders of usMIMA met in Moebio’s dHEALTH BCN program, a disruptive talent development initiative powered by Biocat and inspired by Stanford Biodesign.
The usMIMA team has developed MOWOOT to improve the quality of life of those affected by constipation. And both, to ensure MOWOOT’s success and to complete the information already available in their clinical trials, they are personally assisting you with advise to resolve your doubts about the product.
Collaborations and recognitions
MOWOOT has been developed with the collaboration of Institut Guttmann, a reference hospital in Europe in the field of neurorehabilitation, and has received numerous awards and recognitions.
MOWOOT and usMIMA have received multiple awards, certifications and acknowledgments that support the effectiveness of this solution for chronic constipation:
First Prize BioEmprendedorXXI, promoted by La Caixa, BarcelonaActiva, Barcelona City Council and Biocat
First Prize Everis Award, section “Biotechnology and Health”, promoted by Everis Foundation and Everis Group
Recognition as one of the "TOP 10 innovative startups with social impact in Spain" by TEDx Binnenhof / European Commission and ENISA
Quality label "Innovative SME" of MINECO (Ministry of Economy and Competitiveness) (December 2015)
European Commission / Horizon 2020 Seal of Excellence
CE certification as a class IIa medical device, subject to special controls to demonstrate its safety and effectiveness. This certification guarantees that MOWOOT complies with the quality standards of the European Union
29 May, 2017
Immaculada Herrero, CSO of usMIMA has been invited to the program Tot és possible from the leading radio network in ...
29 April, 2017
The health program Verd Primera on the Barcelona TV Beteve, reports on the development of MOWOOT with the Institut Guttmann, ...
29 April, 2017
The radio channel Radio 4 from RNE interviews Markus Wilhelms, CEO of usMIMA, in the Club 21 program. Wilhelms explains what MOWOOT ...
29 April, 2017
The science program Què Qui Com of Canal 33 emits an episode about constipation and good depositional habits in which Inmaculada ...
The usMIMA team
CEO and co-founder.
Doctor in Molecular Microbiology.
CSO and co-founder.
Doctor in Biological Sciences by the Department of Medicine.
CRMO and cofounder.
Master in Engineering of the Design specialized in Industrial Prototyping.
CTO and co-founder.
Doctor in Information and Communication Technologies and its management.
Do you have any doubts?
Leave us your contact information and we advise you.